The future of real-world evidence
Biopharma is placing greater emphasis on real-world evidence (RWE), a Deloitte life-sciences survey finds. RWE helps leaders show value for access, understand the patient journey, and provide more data.
Embracing the future of work to unlock R&D productivity
Future of life sciences regulation: How industry, regulators and patients can succeed together
Preparing for the future
The future awakens
Survey finds biopharma companies lag in digital transformation
Here’s how companies can take an enterprisewide approach to digital transformation—including strategic changes to leadership and talent, as well as funding.